Catalyst Wire Dossier Catalyst Wire Dossier

Sorafenib

Sorafenib · Dr. Reddy's Laboratories Inc
Drug timelines are a Plus or Pro feature.

318 regulatory and trial events tracked for Sorafenib, covering 2008-09-15 to 2026-08-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab [Phase 3]

See pricing